Intellia Therapeutics, Inc. NTLA
NasdaqGM β’ Real-Time Technical Indicators & Signals β’ Currency: USD
Automated Algorithmic Diagnosis
REAL-TIMEAlgorithmic Technical Summary for Intellia Therapeutics, Inc. (NTLA): As of current market pricing, NTLA is trading at $9.52 (-0.25 (-2.56%)). Technical indicator diagnostics show a 14-day Relative Strength Index (RSI) of 35.75, indicating a Bearish Momentum condition. The daily MACD (Moving Average Convergence Divergence) indicator is currently registered at -0.61 versus the signal line of -0.38, giving a histogram reading of -0.23 (Bearish Pressure). From a structural trend perspective, NTLA is trading -20.8% below its 200-day exponential moving average ($12.02), classifying the prevailing institutional trend bias as Strong Bearish Pressure.
NTLA Price & Trend Overlay (Last 90 Days)
Looking to buy or trade Intellia Therapeutics, Inc. (NTLA)?
Trade TSX and US stocks with low commissions on Questrade. Open a TFSA, RRSP, or Margin account and receive a $50 cash reward with promo code 386513194498114.
Technical Indicators & Market Metrics Table
| Indicator / Metric | Current Value | Technical Status | Market Interpretation |
|---|---|---|---|
| RSI (14) | 35.75 | Bearish Momentum | RSI at 35.75 indicates moderate bearish pressure and weak buying appetite. |
| MACD Line (12, 26) | -0.61 | Bearish Pressure | Signal line: -0.38, Histogram: -0.23 |
| 20-Day EMA | $10.92 | Bearish | Short-term momentum guide. Price is trading under $10.92. |
| 50-Day EMA | $11.57 | Bearish | Medium-term trend indicator. Institutional support/resistance band. |
| 200-Day EMA | $12.02 | Long-Term Downtrend | Major institutional baseline. Distance to 200 EMA: -20.8%. |
| Average True Range (ATR 14) | $0.83 | Volatility | Expected average daily dollar price fluctuation. |
| 52-Week Range | $7.95 - $18.48 | Annual Range | Current price is $9.52 within the 52-week envelope. |
| Volume vs 30d Avg | 9.96M / 5.15M | Liquidity | Market Cap: 1.34B β’ P/E Ratio: N/A |
Technical Setups From Our Latest Scan
Stocks currently flagged by our RSI, MACD and EMA scan. See the full lists: oversold stocks Β· overbought stocks Β· MACD crossovers Β· Golden Cross Β· EMA screener Β· TSX scanner.
Frequently Asked Questions about Intellia Therapeutics, Inc. (NTLA)
Q: What is NTLA's RSI (Relative Strength Index) today?
As of today, Intellia Therapeutics, Inc. (NTLA) has a 14-day RSI of 35.75. This indicates a Bearish Momentum condition. Traders use RSI readings below 30 to identify oversold conditions and readings above 70 to identify overbought conditions.
Q: Is NTLA's MACD indicator bullish or bearish?
The daily MACD line for NTLA is currently -0.61 compared to its 9-day signal line of -0.38, generating a histogram difference of -0.23. This translates to a Bearish Pressure signal.
Q: Where is NTLA trading relative to its 200-day EMA?
NTLA is currently trading at $9.52, which is -20.8% below its 200-day exponential moving average of $12.02. Staying above the 200 EMA is considered a primary benchmark for institutional bull market trends.
Q: What are key support and resistance levels for NTLA?
Immediate support sits around the 20-day EMA ($10.92) and recent 20-day swing low ($9.52). Immediate resistance is marked near the 20-day high ($13.32) and the 52-week high of $18.48.